118 research outputs found
The feasibility of milkfish (Chanos chanos) aquaculture in Solomon Islands
Fish is crucial to food and nutrition security in Solomon Islands, and demand is expected to increase due to a growing population. However, it is projected that current capture fisheries production will not meet this growing demand. Aquaculture has the potential to mitigate the capture fishery shortfall, and the Government of Solomon Islands is prioritizing aquaculture as a solution to meet future food and income needs. Aquaculture in Solomon Islands is still in early development. Mozambique tilapia (Oreochromis mossambicus) is farmed for household consumption, but its prolific reproductive rate and resulting slow growth limit its potential as a commercial aquaculture species. More productive fish species that are not indigenous to Solomon Islands but are successfully farmed overseas could be introduced; however, such a decision needs to take into account the potential ecological or social impacts. For land-based pond aquaculture, the only indigenous species that has been farmed extensively elsewhere is milkfish (Chanos chanos). This report presents a feasibility assessment for milkfish farming in Solomon Islands. It synthesizes the current knowledge about milkfish farming and presents results of a 4-year study on the potential for milkfish aquaculture in Solomon Islands
Fermented wheat germ extract - nutritional supplement or anticancer drug?
<p>Abstract</p> <p>Background</p> <p>Fermented wheat germ extract (FWGE) is a multisubstance composition and, besides others, contains 2-methoxy benzoquinone and 2, 6-dimethoxy benzoquinone which are likely to exert some of its biological effects. FWGE interferes with anaerobic glycolysis, pentose cycle and ribonucleotide reductase. It has significant antiproliferative effects and kills tumor cells by the induction of apoptosis via the caspase-poly [ADP-ribose] polymerase-pathway. FWGE interacts synergistically with a variety of different anticancer drugs and exerted antimetastatic properties in mouse models. In addition, FWGE modulates immune response by downregulation of MHC-I complex and the induction of TNF-α and various interleukins. Data in the F-344 rat model provide evidence for a colon cancer preventing effect of FWGE.</p> <p>Clinical data from a randomized phase II trial in melanoma patients indicate a significant benefit for patients treated with dacarbazine in combination with FWGE in terms of progression free survival (PFS) and overall survival (OS). Similarly, data from studies in colorectal cancer suggested a benefit of FWGE treatment. Besides extension of OS and PFS, FWGE improved the quality of life in several studies.</p> <p>Conclusion</p> <p>In conclusion, available data so far, justify the use of FWGE as a non-prescription medical nutriment for cancer patients. Further randomized, controlled and large scale clinical studies are mandatory, to further clarify the value of FWGE as a drug component of future chemotherapy regimens.</p
Grambank reveals the importance of genealogical constraints on linguistic diversity and highlights the impact of language loss
While global patterns of human genetic diversity are increasingly well characterized, the diversity of human languages remains less systematically described. Here we outline the Grambank database. With over 400,000 data points and 2,400 languages, Grambank is the largest comparative grammatical database available. The comprehensiveness of Grambank allows us to quantify the relative effects of genealogical inheritance and geographic proximity on the structural diversity of the world's languages, evaluate constraints on linguistic diversity, and identify the world's most unusual languages. An analysis of the consequences of language loss reveals that the reduction in diversity will be strikingly uneven across the major linguistic regions of the world. Without sustained efforts to document and revitalize endangered languages, our linguistic window into human history, cognition and culture will be seriously fragmented.Genealogy versus geography Constraints on grammar Unusual languages Language loss Conclusio
Pancreatic beta cell protection/regeneration with phytotherapy
Although currently available drugs are useful in controlling early onset complications of diabetes, serious late onset complications appear in a large number of patients. Considering the physiopathology of diabetes, preventing beta cell degeneration and stimulating the endogenous regeneration of islets will be essential approaches for the treatment of insulin-dependent diabetes mellitus. The current review focused on phytochemicals, the antidiabetic effect of which has been proved by pancreatic beta cell protection/regeneration. Among the hundreds of plants that have been investigated for diabetes, a small fraction has shown the regenerative property and was described in this paper. Processes of pancreatic beta cell degeneration and regeneration were described. Also, the proposed mechanisms for the protective/regenerative effects of such phytochemicals and their potential side effects were discussed
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) : part two
Background
The immunological escape of tumors represents one of the main ob- stacles to the treatment of malignancies. The blockade of PD-1 or CTLA-4 receptors represented a milestone in the history of immunotherapy. However, immune checkpoint inhibitors seem to be effective in specific cohorts of patients. It has been proposed that their efficacy relies on the presence of an immunological response. Thus, we hypothesized that disruption of the PD-L1/PD-1 axis would synergize with our oncolytic vaccine platform PeptiCRAd.
Methods
We used murine B16OVA in vivo tumor models and flow cytometry analysis to investigate the immunological background.
Results
First, we found that high-burden B16OVA tumors were refractory to combination immunotherapy. However, with a more aggressive schedule, tumors with a lower burden were more susceptible to the combination of PeptiCRAd and PD-L1 blockade. The therapy signifi- cantly increased the median survival of mice (Fig. 7). Interestingly, the reduced growth of contralaterally injected B16F10 cells sug- gested the presence of a long lasting immunological memory also against non-targeted antigens. Concerning the functional state of tumor infiltrating lymphocytes (TILs), we found that all the immune therapies would enhance the percentage of activated (PD-1pos TIM- 3neg) T lymphocytes and reduce the amount of exhausted (PD-1pos TIM-3pos) cells compared to placebo. As expected, we found that PeptiCRAd monotherapy could increase the number of antigen spe- cific CD8+ T cells compared to other treatments. However, only the combination with PD-L1 blockade could significantly increase the ra- tio between activated and exhausted pentamer positive cells (p= 0.0058), suggesting that by disrupting the PD-1/PD-L1 axis we could decrease the amount of dysfunctional antigen specific T cells. We ob- served that the anatomical location deeply influenced the state of CD4+ and CD8+ T lymphocytes. In fact, TIM-3 expression was in- creased by 2 fold on TILs compared to splenic and lymphoid T cells. In the CD8+ compartment, the expression of PD-1 on the surface seemed to be restricted to the tumor micro-environment, while CD4 + T cells had a high expression of PD-1 also in lymphoid organs. Interestingly, we found that the levels of PD-1 were significantly higher on CD8+ T cells than on CD4+ T cells into the tumor micro- environment (p < 0.0001).
Conclusions
In conclusion, we demonstrated that the efficacy of immune check- point inhibitors might be strongly enhanced by their combination with cancer vaccines. PeptiCRAd was able to increase the number of antigen-specific T cells and PD-L1 blockade prevented their exhaus- tion, resulting in long-lasting immunological memory and increased median survival
Cardioprotective effect of lipistat against doxorubicin induced myocardial toxicity in albino rats
41-46Preventive role of lipistat against doxorubicin induced myocardial toxicity in rats has been reported.. Cardiotoxicity was produced by doxorubicin administration (15 mg/kg for 2 weeks). Lipistat (350 mg/kg, orally) was administered as pretreatment for 2 weeks and then for 2 weeks alternated with doxorubicin. The general observations, mortality, histopathology, biomarker enzymes like lactate dehydrogenase (LDH) and creatine phosphokinase (CPK), serum lipid profiles like total cholesterol, triglycerides, low-density lipoprotein (LDL) and high-density lipoprotein (HDL), antioxidant enzymes such as glutathione (GSH), superoxide dismutase (SOD) and catalase (CAT) were monitored after 3 weeks of last dose. Pretreatment with the lipistat significantly protected myocardium from the toxic effects of doxorubicin by reducing the elevated level of biomarker enzymes like LDH and CPK to the normal and serum lipids such as total cholesterol, triglyceride and LDL back to normal. Lipistat increases the decreased level of GSH, SOD and CAT and decreases the increased level of malondialdehyde in cardiac tissue. The repeated administration of doxorubicin causes cardiomyopathy associated with an antioxidant deficit and increased level of lipid profiles by interfering with fatty acid metabolism. The results support the lipid lowering and antioxidant properties of lipistat, which indicate the cardioprotective property against doxorubicin induced cardiotoxicity
Cardioprotective effect of ascorbic acid on doxorubicin-induced myocardial toxicity in rats
Objective : To investigate the preventive and curative role of ascorbic
acid on doxorubicin (dox)-induced myocardial toxicity in rats.
Materials and Methods : Animals were divided into five groups of six
animals each. Group I served as normal control and received saline 5
ml/kg/day intraperitoneal (i.p.) for a period of 15 days. Group II
animals received ascorbic acid 20 mg/kg per oral (p.o.) for 15 days as
a pretreatment control (PR). Group III animals received dox 2.5 mg/kg
body weight (b.w.), i.p., in six equal injections for two weeks for a
total cumulative dose of 15 mg/kg b.w. Group IV animals received
ascorbic acid 20 mg/kg p.o. for 15 days as a pretreatment followed by
dox 2.5 mg/kg b.w., i.p., in six equal injections for two weeks for a
total cumulative dose of 15 mg/kg body weight. Group V animals received
dox 2.5 mg/kg b.w., i.p., in six equal injections for two weeks for a
total cumulative dose of 15 mg/kg b.w. followed by ascorbic acid 20
mg/kg p.o for 15 days as post-treatment control (CR). The biochemical
parameters such as tissue glutathione (GSH), malondialdehyde (MDA),
catalase (CAT), and superoxide dismutase (SOD), and enzyme biomarkers
such as creatine phosphokinase (CPK), lactate dehydrogenase (LDH),
aspartate aminotransferase (AST), and alanine aminotransferase (ALT)
were monitored. Results : Pretreatment with ascorbic acid (20 mg/kg
p.o.) significantly protected the myocardium from the toxic effect of
dox (PR), by increasing the levels of antioxidant enzymes such as GSH,
SOD, and CAT toward normal and decreased the levels of MDA, CPK, LDH,
AST, and ALT as compared with dox-treated rats. Post-treatment with
ascorbic acid to dox-treated group (CR) significantly increased the
levels of tissue GSH, SOD, CAT and significantly decreased the level of
MDA as compared with dox-treated group. It also reduced the severity of
cellular damage of the myocardium as confirmed by histopathology. The
restoration of the endogenous antioxidant system clearly depicts that
ascorbic acid produced its protective effect by scavenging the reactive
oxygen species. Conclusion : The results obtained in this study provide
evidence for the usefulness of the ascorbic acid as a cardioprotective
agent
Alcoholic leaf extract of Plectranthus amboinicus regulates carbohydrate metabolism in alloxan-induced diabetic rats
Objective: The present investigation was undertaken to explore the
possible mechanisms of Plectranthus amboinicus leaf extract in
alloxan-induced diabetic rats. Materials and Methods: Control and
alloxan-induced diabetic albino rats received different treatments;
orally control (vehicle), 200 mg/kg and 400 mg/kg of ethanol extract of
Plectranthus amboinicus (PAEE) and 600 μg/kg of glibenclamide
(standard) for 15 days. At the end of the experiment, the animals were
sacrificed and enzyme activities of carbohydrate metabolism were
measured in the liver. Results: Diabetic control rats showed a
significant elevation (P < 0.001) in fasting blood glucose on
successive days of the experiment as compared with their basal values,
which was maintained over a period of 2 weeks. Daily oral treatment
with PAEE showed a significant reduction (P < 0.001) in the blood
glucose levels on successive days of the experiment as compared with
their basal values. The most pronounced antihyperglycemic effect was
obtained with the dose of 400 mg/kg. PAEE shows a dose-dependent
reduction in gluconeogenic enzymes like glucose-6-phosphatase and
fructose-1,6-disphosphatase. After 15 days of treatment with PAEE,
glycolytic enzymes like phosphoglucoisomerase resulted in a significant
increase with a concomitant significant decrease in the activities of
aldolase. On the other hand, glucose-6-phosphate dehydrogenase was
significantly improved in diabetic rats on administration of PAEE; the
400 mg/kg dose of PAEE elicited a more potent effect compared with the
200 mg/kg dose. Conclusion: The results obtained in this study provide
evidence of the antidiabetic activity of PAEE, mediated through the
regulation of carbohydrate metabolic enzyme activities
- …